Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies clinical trial (NCT04282044). Contact the study team or your healthcare provider for specific answers.

Question 2

How does CRX100 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies clinical trial (NCT04282044). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment process look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies clinical trial (NCT04282044). Contact the study team or your healthcare provider for specific answers.

Question 4

What kind of side effects should I expect from CRX100 and Pembrolizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies clinical trial (NCT04282044). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies clinical trial (NCT04282044). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies clinical trial (NCT04282044). Contact the study team or your healthcare provider for specific answers.

What this study is about